SURG $3.87 Synergetics announces FDA clearance of VersaVIT vitrectomy system (SURG) 3.87 +0.07 : Co announces has received 510(k) clearance from the FDA for VersaVIT, a novel vitrectomy system for the retinal surgery market. "We believe that VersaVIT is a 'game changer' given its functionality, portability and competitive pricing relative to traditional vitrectomy systems." The Company is awaiting CE mark approval, which has been submitted and is currently under review.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.